Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oopherectomy: A case for recommending hysterectomy at surgical prophylaxis
Paley P.J., Swisher E.M., Garcia RLet al. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oopherectomy: a case for recommending hysterectomy at surgical prophylaxis. Gynecol Oncol. 80:2001;176-180.
Germline BRCA2 mutation in a patient with fallopian tube carcinoma: A case report
May
Rose P.G., Shrigley R., Wiesner G.L. Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report. Gynecol Oncol. 77(2):2000;319-320. May.
Molecular evidence linking primary cancer of the fallopian tube to BRCA 1 germ line mutations
January
Zweemer R.P., Van Diest P.J., Verheijen RHet al. Molecular evidence linking primary cancer of the fallopian tube to BRCA 1 germ line mutations. Gynecol Oncol. 76(1):2000;45-50. January.
Occult ovarian tumours in women with BRCA1 or BRCA2 mutations undergoing prophylactic oopherectomy
Lu K.H., Garber J.E., Cramer DWet al. Occult ovarian tumours in women with BRCA1 or BRCA2 mutations undergoing prophylactic oopherectomy. J Clin Oncol. 18(14):2000;2728-2732.
(2000)J Clin Oncol, vol.18, Issue.14, pp. 2728-2732
Clear cell carcinoma of the fimbria of the fallopian tube in a BRCA1 carrier prophylactic surgery
Hartley A., Rollason T., Spooner D. Clear cell carcinoma of the fimbria of the fallopian tube in a BRCA1 carrier prophylactic surgery. Clin Oncol (R Coll Radiol). 12(1):2000;58-59.
Recommendation for follow up care of individuals with an inherited predisposition to cancer. II: BRCA 1 and BRCA 2
March 26
Recommendation for follow up care of individuals with an inherited predisposition to cancer. II: BRCA 1 and BRCA 2. JAMA. 277(12):1997;997-1003. March 26.
Decision analysis - Effects of prophylactic mastectomy and oopherectomy on live expectancy among women with BRCA 1 or BRCA 2 mutations
May 15
Schraget al. Decision analysis - effects of prophylactic mastectomy and oopherectomy on live expectancy among women with BRCA 1 or BRCA 2 mutations. N Engl J Med. 336(20):1997;1465-1471. May 15.
(1997)N Engl J Med, vol.336, Issue.20, pp. 1465-1471